Phase II trial of bryostatin 1 in patients with relapsed low-grade non- Hodgkin's lymphoma and chronic lymphocytic leukemia

Mary L. Varterasian, Ramzi M. Mohammad, Muhammad S. Shurafa, Kim Hulburd, Pamela A. Pemberton, Dorothy H. Rodriguez, Virginia Spadoni, David S. Eilender, Anthony Murgo, Nathan Wall, Maria Dan, Ayad M. Al-Katib

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)825-828
Number of pages4
JournalClinical Cancer Research
Volume6
Issue number3
StatePublished - Mar 2000
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Lactones/adverse effects
  • Bryostatins
  • Macrolides
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy
  • Lymphoma, Non-Hodgkin/drug therapy
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Pain/chemically induced
  • Immunophenotyping
  • Male
  • Treatment Outcome
  • Remission Induction
  • Disease Progression
  • Vincristine/administration & dosage
  • Feasibility Studies
  • Flow Cytometry
  • Fatigue/chemically induced
  • Adult
  • Antineoplastic Agents/adverse effects
  • Female
  • Nervous System Diseases/chemically induced
  • Aged

Cite this